HKD 0.6
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -462.57 Million CNY | -13.72% |
2022 | -406.74 Million CNY | 76.29% |
2021 | -1.71 Billion CNY | -431.29% |
2020 | -322.9 Million CNY | 26.17% |
2019 | -437.35 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -66.86 Million CNY | 40.55% |
2024 Q2 | -66.86 Million CNY | 0.0% |
2023 Q1 | -118.82 Million CNY | -17.26% |
2023 FY | -462.57 Million CNY | -13.72% |
2023 Q4 | -112.46 Million CNY | 0.0% |
2023 Q3 | -112.46 Million HKD | 5.35% |
2023 Q2 | -118.82 Million CNY | 0.0% |
2022 Q2 | -102.03 Million CNY | 0.0% |
2022 Q1 | -102.03 Million CNY | 71.68% |
2022 FY | -406.74 Million CNY | 76.29% |
2022 Q4 | -101.33 Million CNY | 0.0% |
2022 Q3 | -101.33 Million CNY | 0.69% |
2021 Q3 | -360.32 Million CNY | 61.04% |
2021 Q4 | -360.32 Million CNY | 0.0% |
2021 Q2 | -924.85 Million CNY | -1220.39% |
2021 Q1 | -70.04 Million CNY | 31.51% |
2021 FY | -1.71 Billion CNY | -431.29% |
2020 Q1 | -24.78 Million CNY | 0.0% |
2020 FY | -322.9 Million CNY | 26.17% |
2020 Q4 | -102.27 Million CNY | 0.0% |
2020 Q3 | -102.27 Million CNY | -14.21% |
2020 Q2 | -89.54 Million CNY | -261.32% |
2019 FY | -437.35 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 752.647% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 2781.565% |